The site will be unavailable in 8 minutes for scheduled maintenance.

$1.00 -0.01 (-0.99%)
2/10/2012 3:59 PM

StemCells, Inc. (NASDAQ:STEM)

CAPS Rating: 2 out of 5

A biopharmaceutical company that operates in one segment, the development of novel cell-based therapeutics designed to treat human diseases and disorders.

Featured Broker Partners


Advertisement